Supplement GMPs, NDI Guidance Should Top CFSAN 2007 Priority List – CRN
This article was originally published in The Tan Sheet
Executive Summary
The Council for Responsible Nutrition urges FDA's Center for Food Safety & Applied Nutrition to make the publication of the good manufacturing practices for dietary supplements final rule a prominent program priority for 2007
You may also be interested in...
FDA Requiring GRAS-Level Safety Standards For NDI Submissions, Experts Say
FDA has gradually raised the safety standard for new dietary ingredients above the level intended by DSHEA, according to several experts
CFSAN Priorities: Industry & Consumer Groups Weigh In On NDIs And More
FDA should accept safety findings from outside expert panels when reviewing new dietary ingredient notifications, CHPA says in Aug. 25 comments on CFSAN priorities
Dietary Supplement Reps Ask FDA For Clarity Across The Board On NDIs
FDA should focus the 75-day premarket notification process specifically on ingredients, not finished products, industry stakeholders asserted at the agency's public meeting on new dietary ingredient (NDI) submissions Nov. 15